REPROPHARM has a total of 24 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2012. It filed its patents most often in WIPO (World Intellectual Property Organization), Canada and France. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are ADALTA PTY LTD, URRMA R & D and SHANGHAI NAT ENG RES CENTER OF ANTIBODY MEDICINE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 5 | |
#2 | Canada | 4 | |
#3 | France | 4 | |
#4 | United States | 4 | |
#5 | Brazil | 3 | |
#6 | China | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Kara Elodie | 20 |
#2 | Maurel Marie-Christine | 18 |
#3 | Casteret Sophie | 12 |
#4 | Decourtye Jeremye | 8 |
#5 | Dupuy Laurence | 8 |
#6 | Decourtye Jeremy | 7 |
#7 | Elodie Kara | 3 |
#8 | Jérémye Decourtye | 2 |
#9 | Durand Guillaume | 2 |
#10 | Reiter Eric | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016038310A1 | Ligand potentializing fsh bioactivity | |
FR3025517A1 | LIGANDS POTENTIATING THE BIOACTIVITY OF GONADOTROPHINS | |
US2014134649A1 | Method and kit for detecting the preovulatory LH peak | |
FR2994482A1 | Composition, method and kit for detection of prevulatory pic of lh | |
WO2013153291A1 | Method and kit for detecting the lh preovulatory surge |